Purpose: To evaluate the dosing and safety of intravenous magnesium sulfate administered via continuous infusion for refractory wheezing.
Materials And Methods: All patients admitted to the pediatric intensive care unit (PICU) between January 1998 and March 2001 who were prescribed magnesium sulfate via continuous infusion were identified via retrospective chart review. The patient's medical history, demographic data, vital signs, magnesium dosing history, and concurrent medications were recorded.
Purpose: To evaluate residents' skills in performing basic mathematical calculations used for prescribing medications to pediatric patients.
Method: In 2001, a test of ten questions on basic calculations was given to first-, second-, and third-year residents at Miami Children's Hospital in Florida. Four additional questions were included to obtain the residents' levels of training, specific pediatrics intensive care unit (PICU) experience, and whether or not they routinely double-checked doses and adjusted them for each patient's weight.